Analysis of the effectiveness of conservative treatment of patients with low-back pain by regenerative injecting therapy
Background. An openlabel clinical study was conducted to evaluate the efficacy and tolerability of regenerative injecting therapy. The purpose of the study: to assess the effectiveness of regenerative injecting therapy, as well as to analyze the degree of effectiveness of this method in patients with vertebrogenic pain syndromes. Materials and methods. The study involved 30 patients of both sexes aged 20 to 60 years with vertebrogenic pain syndromes: chronic lumbalgia, vertebrogenic syndrome due to spondyloarthrosis, radiculopathy. General clinical (clinical and neurological, using scales for pain assessment), instrumental (Xray, magnetic resonance imaging, ultrasound), laboratory methods were used. Results. The results of the study of regenerative injecting therapy showed a statistical improvement in the patients’ condition. According to the longterm results, conservative treatment (regenerative injecting therapy) has been shown to improve physical wellbeing, increase the ability to work, general perception of the quality of life of patients, and also had good tolerability.
Full Text:PDF (Українська)
Nikiforov AS, Avakjan GN, Mendel' OI. Nevrologicheskie oslozhnenija osteohondroza pozvonochnika [Neurological complications of spinal osteochondrosis]. 2nd ed. Moscow: GEOTAR; 2015. 272 p. (in Russian).
Turbina LG. Dorsalgia. Lechaschii Vrach. 2007;(5):12-16. (in Russian).
Bova AA. Modern approaches to the problem of pain in the lower back. Meditsinskie novosti. 2008;(1):36-40. (in Russian).
Kuznetsov VF. Spravochnik po vertebronevrologii: klinika, diagnostika [Handbook of vertebral neurology: clinic, diagnosis]. Minsk; Belarus', 2000. 351 p. (in Russian).
Koes BW, van Tulder MW, Thomas S. Diagnosis and treatment low back pain. BMJ. 2006 Jun 17;332(7555):1430-4. doi: 10.1136/bmj.332.7555.1430.
Nikiforov AS, Mendel' OI. Osteochondrosis and spondyloarthrosis of the spine as a manifestation of a single degenerative process. Modern approaches to treatment. RMJ. 2006;14(23):1708-1713. (in Russian).
Podchufarova EV, Jahno NN. Bol' v spine: rukovodstvo [Back pain: a guide]. 2nd ed. Moscow: GEOTAR; 2013. 368 p. (in Russian).
Morozova OG. Acute back pain: approaches to therapy. Zdorov’ja Ukrai'ny. Nevrologija, Psyhiatrija, Psyhoterapija. 2007;(6-1):22-23. (in Russian).
Klimenko AV, Golovchenko IuI, Kalishchuk-Slobodin TN. Features of management of patients with chronic vertebral pain of lumbosacral localization. Zdorov’ja Ukrai'ny. 2007;(159):38-39. (in Russian).
Devereaux MW. Low back pain. Prim Care. 2004 Mar;31(1):33-51. doi: 10.1016/S0095-4543(03)00114-3.
Van Middelkoop M, Rubinstein SM, Kuijpers T, et al. A systematic review on the effectiveness ofphysical and rehabilitation interventions forchronic non-specific low back pain. Eur Spine J. 2011 Jan;20(1):19-39. doi: 10.1007/s00586-010-1518-3.
Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte and plateletе rich fibrin (L-PRF). Trends Biotechnol. 2009 Mar;27(3):158-67. doi: 10.1016/j.tibtech.2008.11.009.
El-Sharkawy H, Kantarci A, Deady J, et al. Platelet-rich plasma: growth factors and pro and anti-inammatory properties. J Periodontol. 2007 Apr;78(4):661-9. doi: 10.1902/jop.2007.060302.
Everts PA, van Zundert A, Schönberger JP, Devilee RJ, Knape JT. What do we use: platelet-rich plasma or plateletleukocyte gel. J Biomed Mater Res A. 2008 Jun 15;85(4):1135-6. doi: 10.1002/jbm.a.31570.
Frechette JP, Martineau I, Gagnon G. Platelet-rich plasmas: growth factor content and roles in wound healing. J Dent Res. 2005 May;84(5):434-9. doi: 10.1177/154405910508400507.
© Publishing House Zaslavsky, 1997-2019